New drug combo tested for Tough-to-Treat breast cancer
Disease control
Not yet recruiting
This early-stage study is testing whether adding an experimental drug called HRS-6209 to standard hormone therapies (fulvestrant or letrozole) is safe and might help control advanced breast cancer. It will involve about 15 patients whose cancer has specific hormone receptor patte…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC